Platelet Storage Lesion: A New Understanding From a Proteomic Perspective

Transfusion Medicine Reviews

Volumn 22, Issue 4, 2008, Pages 268-279

  Thon, Jonathan N ^a,b   Schubert, Peter ^a,b   Devine, Dana V ^a,b  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BACTERIAL GROWTH; BACTERIUM CONTAMINATION; HUMAN; PROTEOMICS; QUALITY CONTROL; REVIEW; SHELF LIFE; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION;

ALGORITHMS; BLOOD PLATELETS; BLOOD PRESERVATION; HUMANS; MODELS, BIOLOGICAL; PLATELET TRANSFUSION; PROTEOMICS;

EID: 51449099226     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2008.05.004     Document Type: Review

References (122)

1. Page M.J., Griffiths T.A., Bleackley M.R., et al. Proteomics: Applications relevant to transfusion medicine. Transfus Med Rev 20 (2006) 63-74
2. Queloz P.A., Thadikkaran L., Crettaz D., et al. Proteomics and transfusion medicine: Future perspectives. Proteomics 6 (2006) 5605-5614
3. Reddy K.S., and Perrotta P.L. Proteomics in transfusion medicine. Transfusion 44 (2004) 601-604
4. Thadikkaran L., Siegenthaler M.A., Crettaz D., et al. Recent advances in blood-related proteomics. Proteomics 5 (2005) 3019-3034
5. Issaq H.J., Xiao Z., and Veenstra T.D. Serum and plasma proteomics. Chem Rev 107 (2007) 3601-3620
6. Pasini E.M., Kirkegaard M., Mortensen P., et al. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108 (2006) 791-801
7. Garcia A., Prabhakar S., Brock C.J., et al. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 4 (2004) 656-668
8. Maguire P.B., Wynne K.J., Harney D.F., et al. Identification of the phosphotyrosine proteome from thrombin activated platelets. Proteomics 2 (2002) 642-648
9. Perrotta P.L., and Bahou W.F. Proteomics in platelet science. Curr Hematol Rep 3 (2004) 462-469
10. Marcus K., Immler D., Sternberger J., et al. Identification of platelet proteins separated by two-dimensional gel electrophoresis and analyzed by matrix assisted laser desorption/ionization-time of flight-mass spectrometry and detection of tyrosine-phosphorylated proteins. Electrophoresis 21 (2000) 2622-2636
11. O'Neill E.E., Brock C.J., von Kriegsheim A.F., et al. Towards complete analysis of the platelet proteome. Proteomics 2 (2002) 288-305
12. Martens L., Van Damme P., Van Damme J., et al. The human platelet proteome mapped by peptide-centric proteomics: A functional protein profile. Proteomics 5 (2005) 3193-3204
13. Garcia A., Prabhakar S., Hughan S., et al. Differential proteome analysis of TRAP-activated platelets: Involvement of DOK-2 and phosphorylation of RGS proteins. Blood 103 (2004) 2088-2095
14. Garcia A., Senis Y.A., Antrobus R., et al. A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: Involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics 6 (2006) 5332-5343
15. Moebius J., Zahedi R.P., Lewandrowski U., et al. The human platelet membrane proteome reveals several new potential membrane proteins. Mol Cell Proteomics 4 (2005) 1754-1761
16. Garcia B.A., Smalley D.M., Cho H., et al. The platelet microparticle proteome. J Proteome Res 4 (2005) 1516-1521
17. Maynard D.M., Heijnen H.F., Home M.K., et al. Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 5 (2007) 1945-1955
18. Hernandez-Ruiz L., Valverde F., Jimenez-Nunez M.D., et al. Organellar proteomics of human platelet dense granules reveals that 14-3-3zeta is a granule protein related to atherosclerosis. J Proteome Res 6 (2007) 4449-4457
19. Zahedi R.P., Begonja A.J., Gambaryan S., et al. Phosphoproteomics of human platelets: A quest for novel activation pathways. Biochim Biophys Acta 1764 (2006) 1963-1976
20. Lewandrowski U., Zahedi R.P., Moebius J., et al. Enhanced N-glycosylation site analysis of sialoglycopeptides by strong cation exchange prefractionation applied to platelet plasma membranes. Mol Cell Proteomics 6 (2007) 1933-1941
21. Patel S.R., Hartwig J.H., and Italiano Jr. J.E. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 115 (2005) 3348-3354
22. Aster R.H. Pooling of platelets in the spleen: Role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest 45 (1966) 645-657
23. Mason K.D., Carpinelli M.R., Fletcher J.I., et al. Programmed anuclear cell death delimits platelet life span. Cell 128 (2007) 1173-1186
24. White J.G. Electron microscopic studies of platelet secretion. Prog Hemostasis Thromb 2 (1974) 49-98
25. White J.G. Interaction of membrane systems in blood platelets. Am J Pathol 66 (1972) 295-312
26. Cutler L., Rodan G., and Feinstein M.B. Cytochemical localization of adenylate cyclase and of calcium ion, magnesium ion-activated ATPases in the dense tubular system of human blood platelets. Biochim Biophys Acta 542 (1978) 357-371
27. White J.G. Effects of colchicine and vinca alkaloids on human platelets. I. Influence on platelet microtubules and contractile function. Am J Pathol 53 (1968) 281-291
28. McRedmond J.P., Park S.D., Reilly D.F., et al. Integration of proteomics and genomics in platelets: A profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics 3 (2004) 133-144
29. Gnatenko D.V., Dunn J.J., McCorkle S.R., et al. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 101 (2003) 2285-2293
30. Weyrich A.S., Lindemann S., Tolley N.D., et al. Change in protein phenotype without a nucleus: Translational control in platelets. Semin Thromb Hemost 30 (2004) 491-498
31. Weyrich A.S., and Zimmerman G.A. Evaluating the relevance of the platelet transcriptome. Blood 102 (2003) 1550-1551
32. Lindemann S., Tolley N.D., Eyre J.R., et al. Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint for translational control. J Biol Chem 276 (2001) 33947-33951
33. Weyrich A.S., Dixon D.A., Pabla R., et al. Signal-dependent translation of a regulatory protein, Bc1-3, in activated human platelets. Proc Natl Acad Sci U S A 95 (1998) 5556-5561
34. Roth G.J., Hickey M.J., Chung D.W., et al. Circulating human blood platelets retain appreciable amounts of poly (A)+ RNA. Biochem Biophys Res Commun 160 (1989) 705-710
35. Rosenwald I.B., Pechet L., Han A., et al. Expression of translation initiation factors e1F-4E and e1F-2alpha and a potential physiologic role of continuous protein synthesis in human platelets. Thromb Haemost 85 (2001) 142-151
36. Papkoff J., Chen R.H., Blenis J., et al. p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation. Mol Cell Biol 14 (1994) 463-472
37. Kieffer N., Guichard J., Farcet J.P., et al. Biosynthesis of major platelet proteins in human blood platelets. Eur J Biochem 164 (1987) 189-195
38. Booyse F.M., and Rafelson Jr. M.E. Studies on human platelets. I. Synthesis of platelet protein in a cell-free system. Biochim Biophys Acta 166 (1968) 689-697
39. Booyse F., and Rafelson Jr. M.E. In vitro incorporation of amino-acids into the contractile protein of human blood platelets. Nature 215 (1967) 283-284
40. Lindemann S., Tolley N.D., Dixon D.A., et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 154 (2001) 485-490
41. Gailani D., and Renne T. Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol 27 (2007) 2507-2513
42. Kolev K., and Machovich R. Molecular and cellular modulation of fibrinolysis. Thromb Haemost 89 (2003) 610-621
43. Anitua E., Andia I., Ardanza B., et al. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91 (2004) 4-15
44. Sen C.K. The general case for redox control of wound repair. Wound Repair Regen 11 (2003) 431-438
45. Slichter S.J. Controversies in platelet transfusion therapy. Annu Rev Med 31 (1980) 509-540
46. Higby D.J., Cohen E., Holland J.F., et al. The prophylactic treatment of thrombocytopenic leukemic patients with platelets: A double blind study. Transfusion 14 (1974) 440-446
47. Solomon J., Bofenkamp T., Fahey J.L., et al. Platelet prophylaxis in acute non-lymphoblastic leukaemia. Lancet 1 (1978) 267
48. Stanworth S.J., Hyde C., Brunskill S., et al. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?. Br J Haematol 131 (2005) 588-595
49. White II G.C. Congenital and acquired platelet disorders: Current dilemmas and treatment strategies. Semin Hematol 43 (2006) S37-S41
50. Mayer S.A., and Rincon F. Ultra-early hemostatic therapy for acute intracerebral hemorrhage. Semin Hematol 43 (2006) S70-S76
51. Murphy S., and Gardner F.H. Platelet storage at 22 degrees C: Role of gas transport across plastic containers in maintenance of viability. Blood 46 (1975) 209-218
52. Anderson K.C., Lew M.A., Gorgone B.C., et al. Transfusion-related sepsis after prolonged platelet storage. Am J Med 81 (1986) 405-411
53. Heal J.M., Singal S., Sardisco E., et al. Bacterial proliferation in platelet concentrates. Transfusion 26 (1986) 388-390
54. Hillyer C.D., Josephson C.D., Blajchman M.A., et al. Bacterial contamination of blood components: Risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology Am Soc Hematol Educ Program (2003) 575-589
55. Blajchman M.A., Goldman M., and Baeza F. Improving the bacteriological safety of platelet transfusions. Transfus Med Rev 18 (2004) 11-24
56. Brecher M.E., and Hay S.N. Bacterial contamination of blood components. Clin Microbiol Rev 18 (2005) 195-204
57. Blajchman M.A., Beckers E.A., Dickmeiss E., et al. Bacterial detection of platelets: Current problems and possible resolutions. Transfus Med Rev 19 (2005) 259-272
58. Eder A.F., Kennedy J.M., Dy B.A., et al. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: The American Red Cross experience (2004-2006). Transfusion 47 (2007) 1134-1142
59. de Korte D., Curvers J., de Kort W.L., et al. Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 46 (2006) 476-485
60. Castro E., Girones N., Bueno J.L., et al. The efficacy of photochemical treatment with amotosalen HC1 and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets. Transfusion 47 (2007) 434-441
61. Sawyer L., Hanson D., Castro G., et al. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination. Transfusion 47 (2007) 1062-1070
62. Lozano M., Galan A., Mazzara R., et al. Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HC1 and ultraviolet A light stored up to 7 days: Assessment of hemostatic function under flow conditions. Transfusion 47 (2007) 666-671
63. Nussbaumer W., Allersdorfer D., Grabmer C., et al. Prevention of transfusion of platelet components contaminated with low levels of bacteria: A comparison of bacteria culture and pathogen inactivation methods. Transfusion 47 (2007) 1125-1133
64. Cardigan R., and Williamson L.M. The quality of platelets after storage for 7 days. Transfus Med 13 (2003) 173-187
65. Evaluation of stored platelets. Vox Sang 86 (2004) 203-223
66. Fratantoni J.C., Sturdivant B., and Poindexter B.J. Aberrant morphology of platelets stored in five day containers. Thromb Res 33 (1984) 607-615
67. Holme S., and Murphy S. Quantitative measurements of platelet shape by light transmission studies; application to storage of platelets for transfusion. J Lab Clin Med 92 (1978) 53-64
68. Holme S., and Murphy S. Coulter counter and light transmission studies of platelets exposed to low temperature, ADP, EDTA, and storage at 22 degrees. J Lab Clin Med 96 (1980) 480-493
69. Ray V., Chaudhary R., and Singh H. Modified CMI, an essential adjunct to CMI of platelet for quality control during preparation and storage of platelet concentrates. Transfus Apher Sci 29 (2003) 147-149
70. Holme S., and Murphy S. Platelet storage at 22 degrees C for transfusion: Interrelationship of platelet density and size, medium pH, and viability after in vivo infusion. J Lab Clin Med 101 (1983) 161-174
71. Rao A.K., Niewiarowski S., and Murphy S. Acquired granular pool defect in stored platelets. Blood 57 (1981) 203-208
72. Rinder H.M., Snyder E.L., Bonan J.L., et al. Activation in stored platelet concentrates: Correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and beta-thromboglobulin release. Transfusion 33 (1993) 25-29
73. Bode A.P., Orton S.M., Frye M.J., et al. Vesiculation of platelets during in vitro aging. Blood 77 (1991) 887-895
74. George J.N. Platelet membrane glycoproteins: Alternations during storage of human platelet concentrates. Thrombosis Research 8 (1976) 719-724
75. George J.N., Pickett E.B., and Heinz R. Platelet membrane glycoprotein changes during the preparation and storage of platelet concentrates. Transfusion 28 (1988) 123-126
76. George J.N., Pickett E.B., Saucerman S., et al. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 78 (1986) 340-348
77. Jennings L.K., Ashmun R.A., Wang W.C., et al. Analysis of human platelet glycoproteins IIb-IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry. Blood 68 (1986) 173-179
78. Cardigan R., Turner C., and Harrison P. Current methods of assessing platelet function: Relevance to transfusion medicine. Vox Sang 88 (2005) 153-163
79. Maurer-Spurej E., and Chipperfield K. Past and future approaches to assess the quality of platelets for transfusion. Transfus Med Rev 21 (2007) 295-306
80. Akay O.M., Gunduz E., Basyigit H., et al. Platelet function testing during 5-day storage of single and random donor plateletpheresis. Transfus Apher Sci 36 (2007) 285-289
81. Dekkers D.W., De Cuyper I.M., van der Meer P.F., et al. Influence of pH on stored human platelets. Transfusion 47 (2007) 1889-1895
82. 51Cr allows accurate evaluation of platelet viability of stored platelet concentrates. Br J Haematol 84 (1993) 717-723
83. Peter-Salonen K., Bucher U., and Nydegger U.E. Comparison of posttransfusion recoveries achieved with either fresh or stored platelet concentrates. Blut 54 (1987) 207-212
84. Murphy S., Kahn R.A., Holme S., et al. Improved storage of platelets for transfusion in a new container. Blood 60 (1982) 194-200
85. Simon T.L., Nelson E.J., Carmen R., et al. Extension of platelet concentrate storage. Transfusion 23 (1983) 207-212
86. Schiffer C.A., Lee E.J., Ness P.M., et al. Clinical evaluation of platelet concentrates stored for one to five days. Blood 67 (1986) 1591-1594
87. Hogge D.E., Thompson B.W., and Schiffer C.A. Platelet storage for 7 days in second-generation blood bags. Transfusion 26 (1986) 131-135
88. Arnold D.M., Heddle N.M., Kulczycky M., et al. In vivo recovery and survival of apheresis and whole blood-derived platelets: A paired comparison in healthy volunteers. Transfusion 46 (2006) 257-264
89. Vasconcelos E., Figueiredo A.C., and Seghatchian J. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and apheresis. Transfus Apher Sci 29 (2003) 13-16
90. Snyder E.L., Dunn B.E., Giometti C.S., et al. Protein changes occurring during storage of platelet concentrates. A two-dimensional gel electrophoretic analysis. Transfusion 27 (1987) 335-341
91. Ong S.E., and Mann M. Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 1 (2005) 252-262
92. Thiele T., Steil L., Gebhard S., et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 47 (2007) 1221-1233
93. Li J., Xia Y., Bertino A.M., et al. The mechanism of apoptosis in human platelets during storage. Transfusion 40 (2000) 1320-1329
94. Seghatchian J., and Krailadsiri P. Platelet storage lesion and apoptosis: Are they related?. Transfus Apher Sci 24 (2001) 103-105
95. Glenister K.M., Payne K.A., and Sparrow R.L. Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage. Transfusion 48 (2007) 99-107
96. Thon J.N., Schubert P., Duguay M., et al. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 48 (2008) 425-435
97. Thon J.N., and Devine D.V. Translation of glycoprotein IIIa in stored blood platelets. Transfusion 47 (2007) 2260-2270
98. Dale G.L. Coated-platelets: An emerging component of the procoagulant response. J Thromb Haemost 3 (2005) 2185-2192
99. Orr A.W., Pallero M.A., Xiong W.C., et al. Thrombospondin induces RhoA inactivation through FAK-dependent signaling to stimulate focal adhesion disassembly. J Biol Chem 279 (2004) 48983-48992
100. Kinoshita M. Diversity of septin scaffolds. Curr Opin Cell Biol 18 (2006) 54-60
101. Hall P.A., and Russell S.E. The pathobiology of the septin gene family. J Pathol 204 (2004) 489-505
102. Kato K., Martinez C., Russell S., et al. Genetic deletion of mouse platelet glycoprotein Ibbeta produces a Bernard-Soulier phenotype with increased alpha-granule size. Blood 104 (2004) 2339-2344
103. Bode A. Platelet activation may explain the storage lesion in platelet concentrates. Blood Cells 16 (1990) 109-125
104. Wu W.W., Wang G., Baek S.J., et al. Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. J Proteome Res 5 (2006) 651-658
105. Zieske L.R. A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot 57 (2006) 1501-1508
106. Righetti P.G., Castagna A., Antonioli P., et al. Prefractionation techniques in proteome analysis: The mining tools of the third millennium. Electrophoresis 26 (2005) 297-319
107. Watson S.P., Bahou W.F., Fitzgerald D., et al. Mapping the platelet proteome: A report of the ISTH Platelet Physiology Subcommittee. J Thromb Haemost 3 (2005) 2098-2101
108. Gnatenko D.V., Perrotta P.L., and Bahou W.F. Proteomic approaches to dissect platelet function: Half the story. Blood 108 (2006) 3983-3991
109. Svendsen M.S., Rojkjaer R., Kristensen A.T., et al. Impairment of the hemostatic potential of platelets during storage as evaluated by flow cytometry, thrombin generation, and thrombelastography under conditions promoting formation of coated platelets. Transfusion 47 (2007) 2057-2065
110. Rinder H.M., and Snyder E.L. Activation of platelet concentrate during preparation and storage. Blood Cells 18 (1992) 445-456
111. Coppinger J.A., Cagney G., Toomey S., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103 (2004) 2096-2104
112. Zucker M.B., and Borrelli J. Reversible alterations in platelet morphology produced by anticoagulants and by cold. Blood 9 (1954) 602-608
113. Maurer-Spurej E., Pfeiler G., Maurer N., et al. Room temperature activates human blood platelets. Lab Invest 81 (2001) 581-592
114. Hoffmeister K.M., Felbinger T.W., Falet H., et al. The clearance mechanism of chilled blood platelets. Cell 112 (2003) 87-97
115. Hoffmeister K.M., Josefsson E.C., Isaac N.A., et al. Glycosylation restores survival of chilled blood platelets. Science 301 (2003) 1531-1534
116. Wandall H.H., Hoffmeister K.M., Sorensen A.L., et al. Galactosylation does not prevent the rapid clearance of long-term 4°C stored platelets. Blood 111 (2008) 3249-3256
117. Ringwald J., Zimmermann R., and Eckstein R. The new generation of platelet additive solution for storage at 22 degrees C: Development and current experience. Transfus Med Rev 20 (2006) 158-164
118. de Wildt-Eggen J., Nauta S., Schrijver J.G., et al. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: A prospective, randomized study. Transfusion 40 (2000) 398-403
119. Corash L. Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and red cell concentrates. Vox Sang 78 Suppl 2 (2000) 205-210
120. Goodrich R.P. The use of riboflavin for the inactivation of pathogens in blood products. Vox Sang 78 Suppl 2 (2000) 211-215
121. Ruane P.H., Edrich R., Gampp D., et al. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 44 (2004) 877-885
122. Slichter S.J. Platelet transfusion therapy. Hematol Oncol Clin North Am 21 (2007) 697-729